Pre-operative Polysomnography Assessment of Cardiac Surgery Inpatients
Pre-operative PSG Assessment of Cardiac Surgery Inpatients
2 other identifiers
observational
146
1 country
2
Brief Summary
The purpose of this study is to assess the prevalence and morbidity rates of sleep disordered breathing in cardiac surgery patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2007
Typical duration for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 15, 2009
CompletedFirst Posted
Study publicly available on registry
June 17, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedFebruary 6, 2014
February 1, 2014
3.4 years
June 15, 2009
February 5, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Prevalence of Sleep Disordered Breathing in Cardiac Surgery Patients
September 2009
Secondary Outcomes (1)
Assess Post-Operative Complications of Patients with Sleep Disordered Breathing
September 2009
Study Arms (1)
Cardiac Surgeries: CABG, valve replacements
Eligibility Criteria
cardiac surgery patients
You may qualify if:
- Subjects undergoing major cardiovascular surgery (coronary artery bypass graft, valve replacement surgery, or aortic surgery) under general anesthesia.
- Subjects in whom surgery is planned for greater than 1 day but less than 60 days from the time of enrollment.
You may not qualify if:
- Subjects treated for sleep apnea with positive airway pressure (PAP) therapy or oral appliance in the past 30 days.
- Subjects undergoing Maze procedure for atrial fibrillation.
- Subjects unable to comply with study procedures.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cleveland Medical Devices Inclead
- National Institutes of Health (NIH)collaborator
- The Cleveland Cliniccollaborator
- Johns Hopkins Universitycollaborator
Study Sites (2)
Johns Hopkins University
Baltimore, Maryland, 21205, United States
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hani A Kayyali, MS
Cleveland Medical Devices Inc
- PRINCIPAL INVESTIGATOR
Nancy Foldvary, DO
The Cleveland Clinic
- PRINCIPAL INVESTIGATOR
Nancy Collop, MD
Johns Hopkins University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 15, 2009
First Posted
June 17, 2009
Study Start
March 1, 2007
Primary Completion
August 1, 2010
Study Completion
August 1, 2010
Last Updated
February 6, 2014
Record last verified: 2014-02